Bank Julius Baer & Co’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.78M | Sell |
112,321
-28,861
| -20% | -$2.26M | 0.03% | 197 |
|
|
2025
Q1 | $10.2M | Buy |
141,182
+13,746
| +11% | +$996K | 0.03% | 188 |
|
|
2024
Q4 | $10.4M | Buy |
127,436
+31,972
| +33% | +$2.61M | 0.03% | 201 |
|
|
2024
Q3 | $7.56M | Sell |
95,464
-837,997
| -90% | -$66.3M | 0.03% | 210 |
|
|
2024
Q2 | $93.9M | Sell |
933,461
-60,713
| -6% | -$6.11M | 0.36% | 66 |
|
|
2024
Q1 | $94.8M | Buy |
994,174
+33,213
| +3% | +$3.17M | 0.36% | 72 |
|
|
2023
Q4 | $73.3M | Buy |
960,961
+168,350
| +21% | +$12.8M | 0.31% | 81 |
|
|
2023
Q3 | $54.9M | Buy |
792,611
+33,296
| +4% | +$2.31M | 0.32% | 74 |
|
|
2023
Q2 | $71.6M | Sell |
759,315
-8,164
| -1% | -$770K | 0.43% | 59 |
|
|
2023
Q1 | $63.5M | Sell |
767,479
-7,455
| -1% | -$617K | 0.4% | 66 |
|
|
2022
Q4 | $57.8M | Sell |
774,934
-18
| -0% | -$1.34K | 0.39% | 64 |
|
|
2022
Q3 | $64M | Sell |
774,952
-43,197
| -5% | -$3.57M | 0.49% | 54 |
|
|
2022
Q2 | $77.8M | Sell |
818,149
-977,446
| -54% | -$92.9M | 0.55% | 44 |
|
|
2022
Q1 | $211M | Buy |
1,795,595
+46,253
| +3% | +$5.44M | 1.27% | 22 |
|
|
2021
Q4 | $227M | Buy |
1,749,342
+182,080
| +12% | +$23.6M | 1.21% | 23 |
|
|
2021
Q3 | $177M | Buy |
1,567,262
+189,189
| +14% | +$21.4M | 1.1% | 25 |
|
|
2021
Q2 | $143M | Buy |
1,378,073
+400,567
| +41% | +$41.5M | 0.91% | 30 |
|
|
2021
Q1 | $81.8M | Sell |
977,506
-233,992
| -19% | -$19.6M | 0.61% | 43 |
|
|
2020
Q4 | $111M | Buy |
1,211,498
+171,479
| +16% | +$15.6M | 0.91% | 27 |
|
|
2020
Q3 | $83M | Buy |
1,040,019
+128,744
| +14% | +$10.3M | 0.81% | 34 |
|
|
2020
Q2 | $63M | Buy |
911,275
+74,668
| +9% | +$5.16M | 0.73% | 38 |
|
|
2020
Q1 | $52.4M | Buy |
+836,607
| New | +$52.4M | 1.21% | 20 |
|